SEC Filings
Dimensional Fund Advisors Reports 5.5% Gap Position, All Held Through Its Funds
A passive Schedule 13G lists 19,186,720 Gap shares, with sole voting power over 18,820,280, and a certification of no intent to influence control.
SEC Filings
A passive Schedule 13G lists 19,186,720 Gap shares, with sole voting power over 18,820,280, and a certification of no intent to influence control.
SEC Filings
The Schedule 13G covers 3,722,188 shares held by funds Dimensional advises, and certifies no intent to influence control.
SEC Filings
The passive filing lists 2,665,304 shares, with sole voting power over 2,612,217 of them.
SEC Filings
The 13G shows a September 30 event date, before Crescent's Devon Eagle Ford deal and $1 billion stock offering were announced.
SEC Filings
The fund manager lists 6,089,754 shares held through funds it advises, and certifies it is not seeking control.
SEC Filings
The 10-Q's subsequent-events note says Honroth succeeds Jim Clemmer on November 2, while cash fell from $53.86 million at May 31.
SEC Filings
Kirby says the planned exit follows its 2026 annual report, and the controller stays in his roles through the handover.
SEC Filings
The 8-K says holders get 100% of principal plus accrued interest, and no 4.25% notes due December 2027 will remain outstanding.
SEC Filings
The share-for-share Donlin Gold deal needs 66 2/3% of votes cast, with a lock-up and standstill on the shares Paulson receives.
SEC Filings
The company also created three senior roles and said 2026 results should land at the high end of its August 4 outlook.
SEC Filings
The designation covers late-line metastatic castration-resistant prostate cancer; Vir and Astellas co-develop the drug.
SEC Filings
A Schedule 13G lists 1,708,659 shares and says none were bought to influence control of the bank holding company.